Junji Kishimoto

6.3k total citations · 1 hit paper
159 papers, 4.5k citations indexed

About

Junji Kishimoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Junji Kishimoto has authored 159 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 50 papers in Oncology and 29 papers in Surgery. Recurrent topics in Junji Kishimoto's work include Lung Cancer Treatments and Mutations (33 papers), Colorectal Cancer Treatments and Studies (14 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Junji Kishimoto is often cited by papers focused on Lung Cancer Treatments and Mutations (33 papers), Colorectal Cancer Treatments and Studies (14 papers) and Lung Cancer Diagnosis and Treatment (14 papers). Junji Kishimoto collaborates with scholars based in Japan, United States and Indonesia. Junji Kishimoto's co-authors include Hirokazu Nagawa, Tsuyoshi Konishi, Toshiaki Watanabe, Nozomu Asukai, Aya Nishizono‐Maher, Noriyuki Kawamura, Hiroshi Katō, Yuko Miyake, Yoshiharu Kim and Toshiaki Watanabe and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Junji Kishimoto

146 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RELIABILIGY AND VALIDITY OF THE JAPANESE-LANGUAGE VERSION OF THE IMPACT OF EVENT SCALE-REVISED (IES-R-J): FOUR STUDIES OF DIFFERENT TRAUMATIC EVENTS

2002 537 citations Nozomu Asukai, Hiroshi Katō et al. The Journal of Nervous and Mental Disease profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junji Kishimoto Japan	35	1.3k	960	827	777	639	159	4.5k
Eik Vettorazzi Germany	40	695 0.5×	1.2k 1.3×	737 0.9×	676 0.9×	143 0.2×	189	4.8k
Miriam Isola Italy	36	448 0.3×	638 0.7×	690 0.8×	416 0.5×	361 0.6×	187	4.4k
John T. Mullen United States	39	1.7k 1.3×	1.8k 1.9×	950 1.1×	1.7k 2.1×	144 0.2×	158	5.2k
Naoko Kinukawa Japan	47	1.1k 0.8×	1.1k 1.2×	901 1.1×	1.4k 1.8×	132 0.2×	191	6.5k
Abha A. Gupta Canada	38	1.2k 0.9×	767 0.8×	421 0.5×	1.5k 2.0×	150 0.2×	241	5.0k
Graciela S. Alarcón United States	57	481 0.4×	729 0.8×	909 1.1×	746 1.0×	180 0.3×	320	12.5k
Birgit I. Lissenberg‐Witte Netherlands	40	1.9k 1.4×	1.6k 1.7×	1.1k 1.3×	1.1k 1.4×	194 0.3×	312	6.5k
Miriam A. Bredella United States	50	652 0.5×	2.7k 2.8×	1.5k 1.9×	819 1.1×	462 0.7×	297	9.6k
Nancy N. Diehl United States	44	1.0k 0.8×	1.5k 1.6×	2.0k 2.4×	1.1k 1.5×	181 0.3×	191	7.8k
Benjamin E. Leiby United States	39	1.3k 0.9×	985 1.0×	681 0.8×	1.0k 1.3×	200 0.3×	234	5.4k

Countries citing papers authored by Junji Kishimoto

Since Specialization

Citations

This map shows the geographic impact of Junji Kishimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Kishimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Kishimoto more than expected).

Fields of papers citing papers by Junji Kishimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Kishimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Kishimoto. The network helps show where Junji Kishimoto may publish in the future.

Co-authorship network of co-authors of Junji Kishimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Kishimoto. A scholar is included among the top collaborators of Junji Kishimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Kishimoto. Junji Kishimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ide, Hisamitsu, et al.. (2025). Prospective observational study to evaluate the feasibility of the mobile app for mild cognitive impairment detection and screening. Frontiers in Digital Health. 7. 1535900–1535900.

Oki, Eiji, Ryota Nakanishi, Koji Ando, et al.. (2024). Recurrence monitoring using ctDNA in patients with metastatic colorectal cancer: COSMOS-CRC-03 and AURORA studies. SHILAP Revista de lepidopterología. 3. 100034–100034. 1 indexed citations

Mizuno, Yumi, Takayuki Hoshina, Kenichiro Yamamura, et al.. (2024). Respiratory viral infections and Kawasaki disease: A molecular epidemiological analysis. Journal of Microbiology Immunology and Infection. 57(5). 691–699. 4 indexed citations

Watanabe, Tatsuya, Takeshi Tohyama, Masataka Ikeda, et al.. (2023). Development of deep-learning models for real-time anaerobic threshold and peak VO2 prediction during cardiopulmonary exercise testing. European Journal of Preventive Cardiology. 31(4). 448–457. 4 indexed citations

Esaki, Mitsuru, Eikichi Ihara, Noriaki Manabe, et al.. (2023). Evaluating the efficacy and safety of acotiamide in patients with esophagogastric junction outflow obstruction: study protocol for an investigator-initiated, multi-center, randomized, double-blind, placebo-controlled phase II trial. Trials. 24(1). 459–459.

Kimura, Kiminori, Tatsuya Kanto, Shinji Shimoda, et al.. (2022). Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study. EBioMedicine. 80. 104069–104069. 34 indexed citations

Hosokawa, Kazuya, Kohtaro Abe, Junji Kishimoto, et al.. (2022). Efficacy and safety of edoxaban in patients with chronic thromboembolic pulmonary hypertension: protocol for a multicentre, randomised, warfarin-controlled, parallel group trial - KABUKI trial. BMJ Open. 12(7). e061225–e061225. 3 indexed citations

Urasaki, Eiichirou, Yasushi Miyagi, & Junji Kishimoto. (2021). Effects of Medications and Subthalamic Nucleus-Deep Brain Stimulation on the Cutaneous Silent Period in Patients With Parkinson's Disease. Neuromodulation Technology at the Neural Interface. 25(6). 854–865. 1 indexed citations

Arima, Mitsuru, Hirosuke Inoue, Shintaro Nakao, et al.. (2021). Study protocol for a multicentre, open-label, single-arm phase I/II trial to evaluate the safety and efficacy of ripasudil 0.4% eye drops for retinopathy of prematurity. BMJ Open. 11(7). e047003–e047003. 2 indexed citations

10.

Hisatomi, Toshio, Hiroshi Enaida, Shigeo Yoshida, et al.. (2020). Safety and efficacy of brilliant blue g250 (BBG) for lens capsular staining: a phase III physician-initiated multicenter clinical trial. Japanese Journal of Ophthalmology. 64(5). 455–461.

11.

Kawano, Yuko, T. Sasaki, Hiroyuki Yamaguchi, et al.. (2018). Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non–small cell lung cancer. Lung Cancer. 125. 136–141. 16 indexed citations

12.

Otsubo, Kohei, Junji Kishimoto, Hirotsugu Kenmotsu, et al.. (2017). Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non–Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis. Clinical Lung Cancer. 19(1). e5–e9. 35 indexed citations

13.

Fujita, Masaki, Takemasa Matsumoto, Hiroshi Wataya, et al.. (2016). The efficacy and safety of cefepime or meropenem in the treatment of febrile neutropenia in patients with lung cancer. A randomized phase II study. Journal of Infection and Chemotherapy. 22(4). 235–239. 3 indexed citations

14.

Hotta, Katsuyuki, Jiichiro Sasaki, Sho Saeki, et al.. (2015). Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non–Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol. Clinical Lung Cancer. 17(1). 75–79. 11 indexed citations

15.

Maekawa, Toshihiko, Junji Kishimoto, Toshiaki Onitsuka, et al.. (2013). Altered visual information processing systems in bipolar disorder: evidence from visual MMN and P3. Frontiers in Human Neuroscience. 7. 403–403. 31 indexed citations

16.

Iwamoto, Chika, Katsuto Takenaka, Shingo Urata, et al.. (2013). The BALB/c-specific polymorphic SIRPA enhances its affinity for human CD47, inhibiting phagocytosis against human cells to promote xenogeneic engraftment. Experimental Hematology. 42(3). 163–171.e1. 37 indexed citations

17.

Hirahashi, Minako, Shinichi Aishima, Junji Kishimoto, et al.. (2011). Significance of dysadherin and E-cadherin expression in differentiated-type gastric carcinoma with submucosal invasion. Human Pathology. 42(4). 558–567. 10 indexed citations

18.

Asukai, Nozomu, et al.. (2008). Pilot study on prolonged exposure of Japanese patients with posttraumatic stress disorder due to mixed traumatic events. Journal of Traumatic Stress. 21(3). 340–343. 14 indexed citations

19.

Asukai, Nozomu, Hiroshi Katō, Noriyuki Kawamura, et al.. (2002). RELIABILIGY AND VALIDITY OF THE JAPANESE-LANGUAGE VERSION OF THE IMPACT OF EVENT SCALE-REVISED (IES-R-J): FOUR STUDIES OF DIFFERENT TRAUMATIC EVENTS. The Journal of Nervous and Mental Disease. 190(3). 175–182. 537 indexed citations breakdown →

20.

Tokita, Hajime, Hiroaki Okamoto, H. Iizuka, et al.. (1996). Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. Journal of General Virology. 77(2). 293–301. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact